These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 9734636)
1. Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders. Guerin J; Smith O; White B; Sweetman G; Feighery C; Jackson J Br J Haematol; 1998 Sep; 102(4):896-902. PubMed ID: 9734636 [TBL] [Abstract][Full Text] [Related]
2. Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients. Guerin J; Casey E; Feighery C; Jackson J Autoimmunity; 1999 Oct; 31(2):109-16. PubMed ID: 10680749 [TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
4. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin. Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415 [TBL] [Abstract][Full Text] [Related]
5. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to beta2-glycoprotein I--a specific marker for the antiphospholipid syndrome. Guerin J; Feighery C; Sim RB; Jackson J Clin Exp Immunol; 1997 Aug; 109(2):304-9. PubMed ID: 9276526 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
8. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort. Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978 [TBL] [Abstract][Full Text] [Related]
9. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
11. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I. Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738 [TBL] [Abstract][Full Text] [Related]
12. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
13. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168 [TBL] [Abstract][Full Text] [Related]
14. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816 [TBL] [Abstract][Full Text] [Related]
15. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748 [TBL] [Abstract][Full Text] [Related]
16. Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Loizou S; Singh S; Wypkema E; Asherson RA Ann Rheum Dis; 2003 Nov; 62(11):1106-11. PubMed ID: 14583576 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria. Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA Front Immunol; 2018; 9():2971. PubMed ID: 30619328 [No Abstract] [Full Text] [Related]